StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SATTVASUKU.BO$0.75+0.00%
Fair $0.75+0.0%

SATTVASUKU.BO

Sattva Sukun Lifecare Limited

Consumer Defensive / Household & Personal ProductsBSE

$0.75

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.75Fund rank 26/100 · Data gapFallback financials|
SA 60/B
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-27.7M · quality 58.3/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

60/100

B

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SATTVASUKU.BOLocal privado en este navegador · Sattva Sukun Lifecare Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$288M

P/E

6.9x

↓

EV/EBITDA

4.8x

↓

ROE

10.4%

↑

Gross Margin

83.5%

↑

Debt/Equity

0.02

↓
52-Week Range$1
$0$1

TradingView lightweight chart

SATTVASUKU.BO price, volumen y niveles de valoración

Último $0.760Periodo -1.9%
Fair value: $0.750

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+50.6%

FCF CAGR

—

FCF margin

-7.1%

FCF / Net income

-0.15x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $52.6M · net income $24.9M · FCF $-3.7M

2022-FY → 2025-FY

Gross margin

83.5%+35.5% pts

Operating margin

53.8%+51.2% pts

Net margin

47.3%+46.0% pts

FCF margin

-7.1%+66.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$52.6M$52.6M$35.5M$22.1M$15.4M
Net Income$24.9M$24.9M$11.9M$5.5M$200000.00
EBITDA$36.6M$36.6M$19.3M$10.2M$1.0M
EPS0.110.110.050.040.00
Gross Margin83.5%83.5%70.9%85.6%48.1%
Operating Margin53.8%53.8%43.5%35.8%2.6%
Net Margin47.3%47.3%33.5%25.0%1.3%
Balance Sheet
Debt/Equity0.020.020.010.020.03
Cash Flow
Free Cash Flow$-3.7M$-3.7M$-27.7M$-30.5M$-11.4M
Returns
ROE10.4%10.4%5.4%3.6%0.5%
Valuation
P/E6.876.8726.0635.39513.49
EV/EBITDA4.824.8215.9719.15103.10
P/B0.720.721.381.252.77
Growth & Yield
Revenue Growth48.1%48.1%60.6%43.7%—
EPS Growth112.2%112.2%44.1%988.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-15.2%

fácil

EPS terminal req.

$0.07

Spread vs growth

127.4%

5Y implied EPS CAGR

-5.9%

fácil

EPS terminal req.

$0.08

Spread vs growth

118.1%

10Y implied EPS CAGR

1.7%

fácil

EPS terminal req.

$0.13

Spread vs growth

110.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -29.0%

Total return

-29.0%

Start / end P/E

20.8x → 7.0x

EPS bridge

0.05 → 0.11

Residual

-74.7%

EPS growth+112.2%
Multiple rerating-66.5%
Dividend+0.0%
Residual / FX / buybacks / cross-term-74.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.